Rasch Analysis of the Premature Ejaculation

Diagnostic Tool (PEDT) and the International

Index of Erectile Function (IIEF) in an Iranian

Sample of Prostate Cancer Patients by Lin, Chung-Ying et al.
RESEARCH ARTICLE
Rasch Analysis of the Premature Ejaculation
Diagnostic Tool (PEDT) and the International
Index of Erectile Function (IIEF) in an Iranian
Sample of Prostate Cancer Patients
Chung-Ying Lin1, Amir H. Pakpour2*, Andrea Burri3,4, Ali Montazeri5
1 Department of Rehabilitation Sciences, Faculty of Health and Social Sciences, The Hong Kong
Polytechnic University, Hung Hom, Hong Kong, 2 Social Determinants of Health Research Center, Qazvin
University of Medical Sciences, Qazvin, Iran, 3 Health and Rehabilitation Research Institute, Auckland
University of Technology, Auckland, New Zealand, 4 Waitemata Pain Service, Department of Anaesthesia
and Perioperative Medicine, North Shore Hospital, Auckland, New Zealand, 5 Mental Health Research
Group, Health Metrics Research Centre, Iranian Institute for Health Sciences Research, ACECR, Tehran,
Iran
* pakpour_amir@yahoo.com; apakpour@qums.ac.ir
Abstract
Background
Male sexual dysfunction is an increasing problem across a variety of general and clinical
populations, such as cancer populations; especially among prostate cancer patients who
tend to receive treatments that often result in erectile dysfunction (ED) and/or premature
ejaculation (PE). Therefore, in order to diagnose ED and PE in these populations, adequate
and efficient instruments such as the International Index of Erectile Function 5-item version
(IIEF-5) and the Premature Ejaculation Diagnostic Tool (PEDT) are needed. However,
since this is an important topic additional evidence of psychometric properties of the IIEF-5
and the PEDT in such samples are required. Thus the aim of the present study was to use
Rasch models to investigate the construct validity, local dependency, score order, and dif-
ferential item functioning (DIF) of both questionnaires in a sample of prostate cancer
patients.
Methods
Prostate cancer patients (n = 1058, mean±SD age = 64.07±6.84 years) who visited urology
clinics were invited to fill out the IIEF-5 and the PEDT. Construct validity was examined
using infit and outfit mean square (MnSq) and local dependency using correlations between
each two residual Rasch scores. Score order was investigated using step and average
measures of difficulty and DIF using DIF contrast.
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Results
All IIEF-5 and PEDT items had acceptable infit and outfit MnSq. Step measures revealed
that all but two items had disordered categories in terms of scores 1 to 3. Only one local
dependency was found, and no items displayed DIF across age, educational level, and help
seeking.
Conclusions
The results showed that both the IIEF-5 and the PEDT had sound psychometric properties
in the Rasch analyses, although some score disordering could be detected in both instru-
ments. The results of no DIF items in both instruments suggest using them to compare ED
and PE across age and educational level is adequate.
Introduction
One in five men suffers from some sort of sexual problem, with prevalence rates showing a
steady increase [1,2]. Erectile dysfunction (ED), together with premature ejaculation (PE), is
the most common male sexual disorder. The largest follow-up study published on the preva-
lence of ED found that only 39.31% of men reported not suffering from ED, whereas 25.14%
had mild ED (that is, experienced ED sometimes), 18.79% moderate ED (that is, usually experi-
enced) and 16.77% complete ED [3]. Reported prevalences for PE range from 10% to 40% [4–
6]. It is estimated that worldwide up to 322 million men will suffer from erectile dysfunction
(ED) in 2025 [7]. Although ED and PE have shown to heavily impact on the quality of life of
men [8], very often sufferers do not seek help from urologist or other specialists because of feel-
ings of shame and embarrassment. In addition, many affected may not have the insight as to
how serious the ED and/or PE problem is, and may resist seeking help until the sexual problem
becomes extremely severe.
While prevalence rates of ED and PE are already high in general population, the estimates
tend to be even higher in clinical samples, such as prostate cancer patients [9,10]. Prostate can-
cer and its treatments (e.g. surgery, radiation, chemotherapy) can have negative impacts on a
patient’s sex life and functioning. Cancer can directly impact on sexual organs, as it is the case
with prostate cancer. It also can affect body image and psycho-emotional health. In addition,
side effects of cancer treatments such as fatigue, pain or anxiety can severely impact on libido
and consequently affect erectile function and sexual satisfaction [9,10]. Many cancer patients
may feel uncomfortable discussing the issue with healthcare professionals. In other words, they
may feel and notice that their sexual function has decreased but they do not know whether this
decrease should be taken serious and or may feel embarrassed to talk about the problem and
actively seek for help. Therefore, there is an urgent need for validated self-report instruments
that allows the patients to efficiently and privately assess their sexual function, and to decide
whether seeking help is necessary. Two commonly used self-reports instruments—the Interna-
tional Index of Erectile Function (IIEF) for the assessment of ED [8,11] and the Premature
Ejaculation Diagnostic Tool (PEDT) for the assessment of PD [12] have been designed for the
above mentioned purpose but validation in prostate cancer patient population is urgently
needed.
While widely applied, the evidence of the psychometric properties of both the IIEF-5 and
PEDT seems insufficient because as to the best of our knowledge, the existing validation studies
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[8,12–14] used primarily classical test theory (CTT). CTT has the major drawback that it treats
the scoring methods inappropriately (e.g., means and standard deviations), and does not differ-
entiate the estimated parameters between items (item difficulty) and respondents (person abil-
ity) [15]. Other statistical methods for the assessment of psychometric properties such as the
Rasch models are able to resolve the CTT drawbacks as they separately assesses person’s ability
and item difficulty [16,17], and convert both item difficulty and person ability into a ratio scale
using the identical unit called logit.
In addition, Rasch models investigate the issues related to the score orders, local depen-
dency, and differential item functioning (DIF), while these issues seem to have never been
investigated in both the IIEF-5 and PEDT. The score orders indicate whether the rated score
reflects the respondents’ condition or not [16]. For example, a respondent who scores 1 (very
low) on the IIEF-5 item should have less severe ED than does a respondent who scores 2 (low).
The local dependency tests whether the IIEF-5 and PEDT items contain latent traits other than
ED and PE, respectively [18]. The DIF shows that whether respondents with different charac-
teristics (e.g., different educational level) interpret IIEF-5 and PEDT item differently [19,20].
The aim of the present study therefore was to add evidence on the psychometric properties
evidence (including construct validity, local dependency, score order, and DIF) of the IIEF-5
and the PEDT in a sample of prostate cancer patients using Rasch models.
Material and Methods
Study population
Between March 2014 and August 2015 a sample of 1202 men who had a diagnosis of prostate
cancer were invited to participate. The sample was recruited from urology clinics affiliated to
medical universities in Tehran, Qazvin, Ahvaz, Guilan, and Tabriz, in Iran. Inclusion criteria
were (1) aged 18 years, (2) being in a stable sexual relationship with a female partner for at
least 6 months, (3) good cognitive function, and (4) voluntary participation. Sixty-three
patients declined to participate, and 81 patients were not eligible because of their impaired cog-
nitive function according to the Mini-Mental State Examination (MMSE; score 23) [21],
resulting in a final sample of 1058 patients. After having their eligibility ascertained by the visit-
ing urologist, participants were asked to complete a set of study questionnaires (see below) in a
private clinic room. All patients provided written informed consent and the study protocol was
approved by the Ethics Committee of Qazvin University of Medical Sciences.
Main outcome measures
Five-item version of the International Index of Erectile Function (IIEF-5). The IIEF-5
represents a short version of the 15-item version of International Index of Erectile Function
used to measure erectile function [8]. The IIEF has received extensive psychometric and cross-
cultural validation and translation [11,22,23], the IIEF-5 seems to be feasible because it con-
tains only five items and has strong evidence on psychometric properties. Recently, an Iranian
version of the IIEF-5 has been developed, showing good psychometric properties [14]. Each
item of the IIEF-5 is rated from 1 (very low; almost never or never; extremely difficult) to 5
(very high; almost always or always; not difficult), with a lower score indicating more erectile
difficulties.
In addition, the sensitivity and specificity of the IIEF-5 have been tested with satisfactory
values in area under receiver operating characteristic curve (AUC). The AUC was 0.97 on a
sample recruited from both the US and the UK [8]. In other words, IIEF-5 has a probability of
97% to accurately identify a man with ED or without ED.
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Premature Ejaculation Diagnostic Tool (PEDT). The PEDT has been designed based on
the diagnostic principles of the DSM-IV-TR for PE [24]. Previous validation studies have
shown satisfactory feasibility, reliability and validity of the PEDT [12]. Similarly, the recently
translated Iranian version of the PEDT also showed good psychometric properties [13]. Origi-
nally, each PEDT item is rated from 0 (not difficult at all; almost never or never; not at all) to 4
(extremely difficult; almost always or always, extremely), with a higher score indicating more
difficulties with premature ejaculation. In the present study, however, the PEDT scores were
recoded from 1 (extremely difficult; almost always or always, extremely) to 5 (not difficult at all;
almost never or never; not at all) in order to correspond to the direction of the IIEF-5 score. As
a result, the higher PEDT scores in our current study indicate less ejaculation problems.
In addition, the sensitivity and specificity of the PEDT have been tested with satisfactory
values in AUC. The AUC was 0.89 for PEDT on an Iranian sample [13]. In other words, PEDT
has a chance of 89%.
Statistical analysis
Descriptive analyses were conducted using SPSS 17.0 (SPSS Inc., Chicago, IL, USA). For
Rasch rating scale models WINSTEPS was used [25]. Because ED and PE were considered as
two separate types of sexual problems, two Rasch models were performed separately—one
for IIEF-5 and another for PEDT. In addition to estimating the difficulty of each IIEF-5 item
and PEDT item, we used information-weighted fit statistic (infit) mean square (MnSq) and
outlier-sensitive fit statistic (outfit) MnSq to determine any redundant (infit or outfit
MnSq < 0.5) or out-of-concept (infit or outfit MnSq> 1.5) item [26]. In other words, if the
item fit well in its belonging construct (ED or PE), both infit and outfit MnSq should be
between 0.5 and 1.5. Rasch models provide separation reliability and separation index (both
included person and item separation), and a value>0.7 suggests good reliability;> 2 suggests
good index [16].
The ordering of the response scores was examined using average difficulty of each response
score (i.e., average measure) and step difficulty of each threshold or boundary between every
two nearby scores (i.e., step measure). Satisfactory ordering of the response scores should
monotonically increase average and step difficulties [27]. We also used Rasch models to test
the local dependency. For that, the correlations (r) of the Rasch residuals between every two
items were computed. That is, we examined whether some items are still correlated after the
same underlying concept has been taken into account, and an r 0.4 is acceptable [28]. Finally,
differential functioning item (DIF) for both the IIEF-5 and PEDT were tested across different
age groups (Group 1:<65 years vs. Group 2:65 years), different education level (Group 1:
<6 educational years vs. Group 2:6 years), and across help seeking (Group 1: no vs. Group 2:
yes). According to other studies [26,29]a DIF was considered substantial when the DIF showed
an absolute contrast (the difficulty for Group 1 minus the difficulty for Group 2)>0.5, mean-
ing that the same item was interpreted in different ways by the two groups.
Results
The mean±SD age (n = 1058), and mean diagnosis duration were 64.07±6.84, and 6.14±3.47
years, respectively. Nearly half of the participants were at stage 2 (n = 462, 43.7%) of prostate
cancer and nearly half were at a medium grade at time of participation (n = 438, 41.4%) accord-
ing to the Gleason grade (Table 1). The mean (SD) scores were between 2.36 (1.70) and 3.10
(1.55) in the IIEF-5; between 1.97 (1.33) and 2.66 (1.45) in the PEDT (Table 2).
Four participants did not respond to all the IIEF-5 and PEDT items and were therefore not
included in the analyses, resulting in a sample of N = 1054 patients used for the Rasch analyses.
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The mean score of each item ranged from 2.36 to 3.10 for the IIEF-5 and from 1.97 to 2.66 for
the PEDT (Table 2). The difficulty was −0.66 to 0.33 for the IIEF-5 and −0.45 to 0.54 for the
PEDT. Infit (0.68 to 1.42 for the IIEF-5; 0.77 to 1.18 for the PEDT) and outfit MnSq (0.57 to
1.43 for the IIEF-5; 0.70 to 1.17 for the PEDT) were acceptable for all individual items. In addi-
tion to the slightly low value for person separation reliability (0.66 for the IIEF-5 and 0.68 for
the PEDT), item separation reliability (0.99), person separation index (1.40), and item sepa-
ration index (9.63) were all satisfactory (Table 2).
Although the average measures were monotonically increased by the categories for all IIEF-
5 and PEDT items, step measures revealed that all but two items (P1, P2) had disordered cate-
gories in terms of scores 1 to 3 (Table 3). The disordered pattern showed that participants
intended not to select score 2 (Fig 1a), and the probabilities of rating on scores 2 to 4 were low
even in the ordering items (Fig 1b).
Only one local dependency was found for the IIEF-5, and none for the PEDT (Table 4). In
addition, no substantial DIF was found in both the IIEF-5 and PEDT across age (<65 years vs.
65 years; DIF contrast = −0.18 to 0.11), educational level (<6 educational years vs.6 educa-
tional years; DIF contrast = −0.13 to 0.13), and seeking help (no vs. yes; DIF contrast = −0.23 to
0.34) (Table 5).
Discussion
The construct validity of the IIEF-5 and PEDT has been previously confirmed by means of fac-
tor analysis using CTT methods [13,14,30], and our present results using Rasch models are in
line with these results also showing satisfactory construct validity for the IIEF-5 and the PEDT,
indicating the usefulness of the two instruments. However, our results additionally reveal other
Table 1. Demographics and clinical characteristics on participants.
Basic characteristics Mean±SD
Age (years) 64.07±6.84
Years of educationa 5.11±1.25
Duration-after-diagnosis (years) 6.14±3.47
Body mass index (kg/m2) 24.34±4.44
Depression score 7.23±4.20
Anxiety score 8.87±4.47
Clinical characteristics n (%)
Stage at diagnosis of prostate cancer
1 166 (15.7%)
2 462 (43.7%)
3 325 (30.7%)
Unknown 90 (8.5%)
Missing 15 (1.4%)
Gleason grade at diagnosis of prostate cancer
Low (Score < 7) 259 (24.5%)
Medium (Score = 7) 438 (41.4%)
High (Score > 7) 248 (23.4%)
Unknown 113 (10.7%)
Diagnosis of erectile dysfunction 698 (66.0%)
Diagnosis of premature ejaculation 380 (36.1%)
a With 1 missing value
doi:10.1371/journal.pone.0157460.t001
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issues related to the questionnaires’ psychometric properties in terms of their score ordering,
local dependency, and DIF items.
Except for the score ordering, all psychometric tests performed in this study suggested that
both IIEF-5 and PEDT are good instruments to assess erectile and ejaculatory problems in
men suffering from prostate cancer. All items fit well in their embedded ED or PE construct
without noise from other unknown concepts as evidenced by our low local dependency analy-
sis. Moreover, no items displaying DIF indicated the appropriate use of combining and com-
paring respondents with different demographics [31]. However, because we only tested DIF
Table 2. Observedmean score, item difficulty and fit statistics for International Index of Erectile Function-5 (IIEF-5) and Premature Ejaculation
Diagnostic Tool (PEDT) (N = 1054).
Scale and item Mean (SD) Difﬁculty Inﬁt Outﬁt
IIEF-5 (Person/Item
reliability = 0.66/0.99;
Person/Item index = 1.40/
10.21)
I1: How did you rate your
conﬁdence that you could
get & keep an erection?
3.10 (1.55) −0.66 1.42 1.39
I2: When you had
erections with sexual
stimulation, how often were
your erections hard enough
for penetration?
2.93 (1.74) −0.24 0.80 0.74
I3: During sexual
intercourse, how often were
you able to maintain your
erection after you had
penetrated your partner?
2.47 (1.66) 0.30 0.68 0.57
I4: During sexual
intercourse, how difﬁcult was
it to maintain your erection to
completion of intercourse?
2.36 (1.70) 0.33 1.41 1.43
I5: When you attempted
sexual intercourse, how
often was it satisfactory to
you?
2.49 (1.67) 0.27 0.74 0.67
PEDT (Person/Item
reliability = 0.68/0.99;
Person/Item index = 1.46/
9.63)
P1: How difﬁcult is it for
you to delay ejaculation?
2.55 (1.36) −0.18 1.18 1.17
P2: Do you ejaculate
before you want to?
2.66 (1.45) −0.45 0.99 0.95
P3: Do you ejaculate with
very little stimulation?
1.97 (1.33) 0.54 1.15 1.13
P4: Do you feel frustrated
because of ejaculating
before you want to?
2.10 (1.44) 0.28 0.77 0.70
P5: How concerned are
you that your time to
ejaculation leaves your
partner sexually unfulﬁlled?
2.45 (1.59) −0.19 0.92 0.89
Note: The rating scale in both IIEF-5 and PEDT uses a 5-point-Likert scale with 1 represents the worst and 5 the best conditions. A higher score in each
item indicates a better sexual ability.
doi:10.1371/journal.pone.0157460.t002
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Table 3. Threshold disordering tests for International Index of Erectile Function-5 (IIEF-5) and Premature Ejaculation Diagnostic Tool (PEDT).
IIEF-5 item # Item score Average
measure
Step measure PEDT item # Item score Average
measure
Step measure
I1 P1
1 = very low −2.77 – 1 = extremely
difﬁcult
−2.75 –
2 = low −1.72 −0.66 2 = very difﬁcult −1.27 −1.34
3 = moderate −0.87 −2.34 3 = moderate
difﬁcult
−0.23 −0.80
4 = high 0.29 −0.30 4 = somewhat
difﬁcult
0.89 0.24
5 = very high 1.98 0.66 5 = not difﬁcult at
all
2.51 1.19
I2 P2
1 = almost never
or never
−1.61 – 1 = almost
always or always
−3.04 –
2 = a few times −0.87 0.81 2 = more than
half the time
−1.32 −1.79
3 = sometimes −0.38 −1.05 3 = about half
the time
−0.34 −0.32
4 = most times 0.21 −1.04 4 = less than half
the time
0.50 −0.05
5 = almost
always or always
1.59 0.31 5 = almost never
or never
1.80 0.34
I3 P3
1 = almost never
or never
−1.08 – 1 = almost
always or always
−1.42 –
2 = a few times −0.32 1.32 2 = more than
half the time
−0.27 0.18
3 = sometimes 0.17 −0.55 3 = about half
the time
0.45 0.08
4 = most times 0.76 −0.36 4 = less than half
the time
1.28 0.46
5 = almost
always or always
2.10 0.79 5 = almost never
or never
2.78 1.45
I4 P4
1 = extremely
difﬁcult
−0.93 – 1 = extremely −1.44 –
2 = very difﬁcult −0.11 0.94 2 = very −0.39 0.23
3 = difﬁcult 0.34 0.28 3 = moderately 0.23 −0.03
4 = slightly
difﬁcult
0.78 0.62 4 = slightly 0.90 0.19
5 = not difﬁcult 1.55 −0.52 5 = not at all 2.16 0.73
I5 P5
1 = almost never
or never
−1.12 – 1 = extremely −1.86 –
2 = a few times −0.35 1.18 2 = very −0.79 −0.30
3 = sometimes 0.15 −0.49 3 = moderately −0.19 −0.17
4 = most times 0.74 −0.32 4 = slightly 0.40 −0.27
5 = almost
always or always
2.05 0.72 5 = not at all 1.51 −0.01
Note: The rating scale in PEDT (1 represents the worst and 5 represents the best ejaculation function) is different from that in the original PEDT (0
represents the best and 4 represents the worst ejaculation function)
doi:10.1371/journal.pone.0157460.t003
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Fig 1. Disordering graph. (A) An example of disordering graph for IIEF-5 (Item 1); the rating scale is a
5-point-Likert scale with 1 represents the worst and 5 the best conditions. (B) An example of ordering graph
for PEDT (Item 1); the rating scale is a 5-point-Likert scale with 1 represents the worst and 5 the best
conditions.
doi:10.1371/journal.pone.0157460.g001
Rasch Analysis of the PEDT and IIEF
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across age, education and help seeking behavior, Clinicians should use both questionnaires
with caution since DIF may be different across other demographic groups. Future studies may
want to further probe into this issue.
The results of the score ordering indicate that most participants preferred not choosing
score 2 when filling out both the IIEF-5 and PEDT. There are several explanations to this find-
ing. First, the patients may not have sufficient cognition to understand the descriptors of score
Table 4. Tests of local dependency for International Index of Erectile Function-5 (IIEF-5) and Premature Ejaculation Diagnostic Tool (PEDT).
IIEF-5 Item # IIEF-5 Item # r PEDT Item # PEDT Item # r
I1 I2 −0.09 P1 P2 −0.19
I3 −0.25 P3 −0.30
I4 −0.43 P4 −0.33
I5 −0.23 P5 −0.29
I2 I3 −0.01 P2 P3 −0.22
I4 −0.35 P4 −0.26
I5 −0.20 P5 −0.34
I3 I4 −0.30 P3 P4 −0.15
I5 −0.04 P5 −0.28
I4 I5 −0.26 P4 P5 −0.07
Absolute r > 0.4, which exceeds the cutoff of correlation for local dependency, is in bold.
doi:10.1371/journal.pone.0157460.t004
Table 5. Tests of differential item functioning (DIF) for International Index of Erectile Function-5 (IIEF-5) and Premature Ejaculation Diagnostic
Tool (PEDT).
Item # on IIEF-5 Difﬁculty DIF contrasta Item # on PEDT Difﬁculty DIF contrasta
Test for age <65 years 65 years Test for age <65 years 65 years
I1 −0.75 −0.56 −0.18 P1 −0.18 −0.18 0.00
I2 −0.19 −0.30 0.11 P2 −0.45 −0.45 0.00
I3 0.32 0.28 0.05 P3 0.49 0.61 −0.12
I4 0.33 0.33 0.00 P4 0.28 0.28 0.00
I5 0.27 0.27 0.00 P5 −0.14 −0.24 0.11
Test for
education
<6 years 6 years Test for
education
<6 years 6 years
I1 −0.60 −0.73 0.13 P1 −0.15 −0.21 0.05
I2 −0.24 −0.24 0.00 P2 −0.42 −0.50 0.07
I3 0.33 0.26 0.07 P3 0.57 0.51 0.06
I4 0.30 0.36 −0.06 P4 0.22 0.35 −0.13
I5 0.23 0.33 −0.10 P5 −0.19 −0.19 0.00
Test for seeking
help
No Yes Test for seeking
help
No Yes
I1 −0.66 −0.56 −0.10 P1 −0.21 0.02 −0.23
I2 −0.24 −0.20 −0.04 P2 −0.45 −0.36 −0.10
I3 0.30 0.28 0.02 P3 0.54 0.61 −0.06
I4 0.33 0.31 0.02 P4 0.32 −0.01 0.34
I5 0.27 0.22 0.06 P5 −0.19 −0.19 0.00
a DIF contrasts were calculated as logit of age < 65 years minus logit of age  65 years; logit of educational year < 6 years minus logit of educational
year  6 years; logit of not seeking help minus seeking help. For age, a positive DIF contrast indicates that those aged < 65 years had a higher item score
than did those aged  65 years, and vice versa. The same interpretation for education and seeking help.
doi:10.1371/journal.pone.0157460.t005
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2. However, because we only recruited patients who had a MMSE score> 23, therefore indicat-
ing unimpaired cognition, this explanation may not be supported. Second, only few of our
participants showed impaired sexual function thus, this may be reflected in the few score 2
responses. Unfortunately, we were unable to obtain the patients’ records with the clinical diag-
nosis to confirm this hypothesis. Third, sexual dysfunction patients may classify the problem
into four levels or less. In other words, when they have a little problem on sexual dysfunction,
they may consider it as no problem. Also, our data cannot answer the third hypothesis; future
studies with sufficient information and solid design are warranted to examine our second and
third hypotheses.
There are some limitations in the present study. First, with the available data we were unable
to explore how many categories should be used in the response scores. Although our results
indicated one disordering score, we are unable to make any assumption or confirm on whether
a 4-point Likert scale would fit better and would show no disordering. Future studies should
further investigate this issue by administering questionnaires using different response scales
(e.g., 3-point vs. 4-point Likert scales). Second, our participants were all diagnosed with a pros-
tate cancer, and our results may not be generalized to general population or other clinical sam-
ples. Third, we did not use any gold standard measures, including objective measures of ED
[32] and PE [33], to test the validity of the IIEF-5 and PEDT. However, this was not considered
a serious limitation since previous studies reported high correlations between both instruments
and the Urologists’ diagnoses [5,12].
Conclusions
Overall, the IIEF-5 and PEDT are two feasible and useful instruments for self-assessment of
ED and PE. All the items fit well in their embedded construct without serious local ependency.
In addition, no items displayed substantial DIF, suggesting that both instruments can be used
in respondents from various demographic backgrounds. However, a certain degree of score dis-
ordering could be detected in both instruments, and future studies will need to further examine
whether using a 4-point Likert scale could perform better than the current 5-point Likert scale.
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